Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

EHA 2016 | EURO-SKI trial: stopping tyrosine kinase inhibitors in a very large cohort of European CML patients

Johan Richter • 9 Jun 2016
EHA 2016
Chronic Myeloid Leukemia
EURO-SKI

Press brief by Johan Richter, MD, PhD of the Skåne University Hospital Lund, Lund, Sweden, at the 2016 Annual Meeting of the European Association of Hematology (EHA), held in Copenhagen, Denmark.

Related Videos

1:48
Do all patients require maintenance therapy following alloSCT?
Mark Levis • 16 Apr 2024
2:02
Optimizing myeloablative conditioning with precision-engineered Orca-T in older patients
Caspian Oliai • 10 Dec 2023
3:21
A Phase I trial of Hu8F4, an anti-PR1/HLA-A2 monoclonal antibody, in R/R myeloid malignancies
Tapan Kadia • 14 Dec 2023
6:31
An overview of trials investigating asciminib in the treatment of Ph+ CML
Michael Mauro • 18 Dec 2023
The content of VJHemOnc is intended for healthcare professionals